MD-reviewed ·  Healthcare editorial
MedAI Verdict
Decision support

Reference AS-200  ·  Clinical Decision Support

Bayesian Health

by Bayesian Health  ·  US

First-ever FDA-cleared continuous AI sepsis monitor (May 2026).

At a glance

Pricing
Enterprise.
HIPAA
Attested
SOC 2
Not disclosed
EHRs
Founded
HQ
US

Bottom line

First-ever FDA-cleared continuous AI sepsis monitor (May 2026).

Free tier available. HIPAA-attested.

Overview

EHR-integrated sepsis early warning + clinical surveillance. First FDA 510(k) for continuous AI sepsis monitoring (May 2026).

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

TierMonthlyAnnualNotes
PlanEnterprise.

Source: vendor pricing page. Verified May 23, 2026.

Compliance + integration

What deploys cleanly

Carries FDA 510(k), HIPAA per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.

Peer-reviewed coverage

What the literature says

1 peer-reviewed study indexed on PubMed evaluate Bayesian Health in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Lessons in machine learning model deployment learned from sepsis.
Lyons PG, Singh K· Med· 2022
In three recent and related publications, researchers from Johns Hopkins University and Bayesian Health report results from implementing and prospectively evaluating the Targeted Real-time Early Warning System (TREWS) for sepsis at five hospitals..

See all on PubMed